These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21427388)

  • 1. Inappropriate tuberculosis treatment regimens in Chinese tuberculosis hospitals.
    Xue He G; van den Hof S; van der Werf MJ; Guo H; Hu YL; Fan JH; Zhang WM; Tostado CP; Borgdorff MW
    Clin Infect Dis; 2011 Apr; 52(7):e153-6. PubMed ID: 21427388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug prescribing practices for tuberculosis in Uzbekistan.
    Hasker E; Khodjikhanov M; Usarova S; Asamidinov U; Yuldashova U; van der Werf MJ; Uzakova G; Veen J
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1405-10. PubMed ID: 19861014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilevel factors affecting tuberculosis diagnosis and initial treatment.
    Thongraung W; Chongsuvivatwong V; Pungrassamee P
    J Eval Clin Pract; 2008 Jun; 14(3):378-84. PubMed ID: 18373583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of anti-tuberculosis drug resistance on treatment outcome of pulmonary tuberculosis patients receiving directly observed treatment strategy in Henan Province, China].
    Wang GJ; Xu JY; Wang GB; Zhen XA; Gao SY; Du CM
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):527-30. PubMed ID: 17074265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment interruptions among patients with tuberculosis in Russian TB hospitals.
    Belilovsky EM; Borisov SE; Cook EF; Shaykevich S; Jakubowiak WM; Kourbatova EV
    Int J Infect Dis; 2010 Aug; 14(8):e698-703. PubMed ID: 20627786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment default and death among tuberculosis patients in Hunan, China.
    Abuaku B; Tan H; Li X; Chen M; Huang X
    Scand J Infect Dis; 2010 Apr; 42(4):281-7. PubMed ID: 20100113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription patterns for tuberculosis treatment and adherence to treatment guidelines: a population-based study in Taiwan.
    Wang SI; Shen GH; Shi HC; Chiou SJ
    Pharmacoepidemiol Drug Saf; 2014 Dec; 23(12):1273-80. PubMed ID: 24962738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to therapy in tuberculosis.
    Cohen FL
    Annu Rev Nurs Res; 1997; 15():153-84. PubMed ID: 9262791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective descriptive study of adult tuberculosis in Wuhan, China.
    Chamla DD; Nie S; Duan Q
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):730-6. PubMed ID: 15182143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi.
    Harries AD; Gausi F; Salaniponi FM
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):724-9. PubMed ID: 15182142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multidrug-resistant tuberculosis management in three French hospitals].
    Greffe S; Gros I; Cruaud P; Hornstein M; Fain O; Poirier C; Abgrall S
    Med Mal Infect; 2011 Jan; 41(1):20-4. PubMed ID: 20801589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and outcome of childhood tuberculosis: implementing public health policy in three districts of Pakistan.
    Safdar N; Hinderaker SG; Baloch NA; Enarson D; Khan MA; Morkve O
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):872-7. PubMed ID: 20550771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of anti-tuberculosis drug resistance in Botswana.
    Talbot EA; Kenyon TA; Mwasekaga MJ; Moeti TL; Mallon V; Binkin NJ
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):72-7. PubMed ID: 12701838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative analysis of tuberculosis treatment success between Hunan Province of China and Eastern Ghana.
    Abuaku BK; Tan H; Li X; Chen M; Huang X
    Med Princ Pract; 2010; 19(6):451-6. PubMed ID: 20881412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of tuberculosis in children.
    Cruz AT; Starke JR
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):939-57. PubMed ID: 19053906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004.
    Bloss E; Kuksa L; Holtz TH; Riekstina V; Skripconoka V; Kammerer S; Leimane V
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):275-81. PubMed ID: 20132617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and planning in national tuberculosis control programmes: the usefulness of the standardised patient treatment card.
    Ipuge YA; Rieder HL; Becx-Bleumink M; Kimerling ME
    East Afr Med J; 1997 Dec; 74(12):816-8. PubMed ID: 9557430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.